
Topic
Immunotherapy
50 Podcasts • 30 Cases • 9 Courses on BackTable
Hear how experienced physicians approach Immunotherapy on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Episode # 59 • 12 May 2026
Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?
With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most likely to shape HCC care? In this final episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhart, and Jon Mizrahi focus on the future of hepatocellular carcinoma beyond established PD-1/CTLA-4 regimens.
More on Immunotherapy
Loading recent podcasts…
Tumor Board Episode #59
May 12, 2026
with Dr. Jonathan Mizrahi, Dr. Lingling Du, Dr. Craig Lockhart
With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most...
100+ listens
VI Episode #641
May 5, 2026
with Dr. Neil Mehta, Dr. Riad Salem, Dr. Tyler Sandow
With recent updates to the Barcelona Clinic Liver Classification (BCLC), how should multidisciplinary teams adapt their...
1,500+ listens
Tumor Board Episode #56
Apr 21, 2026
with Dr. Jessica Jones, Dr. Lindsay Peterson
Here’s a practical guide on how biomarkers can guide treatment and cut costs for your breast cancer patients. In this...
120+ listens
Tumor Board Episode #51
Mar 17, 2026
with Dr. Jennifer McQuade, Dr. Rahul Sheth, Dr. Tyler Sandow
When standard-of-care checkpoint blockade fails in metastatic melanoma, how can oncologists and interventional...
150+ listens
Tumor Board Episode #58
May 5, 2026
with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
100+ listens
Tumor Board Episode #57
Apr 28, 2026
with Dr. Lingling Du, Dr. Craig Lockhart, Dr. Jonathan Mizrahi
Learn how a “watershed” clinical trial in 2020 completely overturned a decade of standard care for liver cancer. In...
150+ listens
Tumor Board Episode #55
Apr 14, 2026
with Dr. Shruti Patel, Dr. Jun Gong
How will the newest colorectal cancer trial results discussed at the 2026 ASCO GI Cancers Symposium in San Francisco...
170+ listens
Tumor Board Episode #50
Mar 10, 2026
with Dr. Ryan Funk, Dr. Dustin Boothe
Though relatively new, there is a rapidly growing interest in the field of therapeutic radiopharmaceuticals and their...
440+ listens
Tumor Board Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Tumor Board Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Tumor Board Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Urology Course
3 hours, 28 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.







